The 21 CFR Part 111 dietary supplement GMP requirements are the FDA’s current good manufacturing practice rules for any company that manufactures, packages, labels, or holds a dietary supplement sold in the United States. Published in 2007, they set enforceable standards for identity, purity, strength, and composition at every stage of production.1Food and Drug Administration. Small Entity Compliance Guide: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements A supplement made under conditions that violate Part 111 is legally adulterated under federal law, which exposes the product to seizure and the company to injunctions or criminal prosecution.2Office of the Law Revision Counsel. 21 USC 342 – Adulterated Food
Who Has to Follow Part 111
Any domestic or foreign facility that manufactures, packages, labels, or holds a dietary supplement intended for the U.S. market is covered. That includes contract manufacturers, third-party packagers, and warehouses that only store finished product. A company handling a single step in the chain is responsible for the CGMP requirements that apply to that step.1Food and Drug Administration. Small Entity Compliance Guide: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements
Retailers such as grocery stores and pharmacies are generally exempt. That exemption ends the moment a retailer repackages, relabels, or produces its own branded supplement, at which point Part 111 applies in full.
Importers carry an additional burden. Under the Foreign Supplier Verification Program, they must conduct risk-based verification that foreign suppliers make supplements under conditions meeting the same public health protections required domestically, and FSVP records are separate from Part 111 documentation.3U.S. Food and Drug Administration. FSMA Final Rule on Foreign Supplier Verification Programs (FSVP) for Importers of Food for Humans and Animals Importers operate under two parallel compliance frameworks.
Written Specifications and Identity Testing
Before using any component, a manufacturer must establish written specifications for identity, purity, strength, composition, and contamination limits. Those contamination limits have to be set low enough to prevent the finished supplement from becoming adulterated.4eCFR. 21 CFR 111.70 – What Specifications Must You Establish? Vague or undocumented specifications are one of the easiest findings for an FDA inspector to write up.
The single most distinctive requirement in Part 111 is 100 percent identity testing of every dietary ingredient. Before a component enters production, the company must conduct at least one appropriate test or examination to confirm the ingredient is what the supplier says it is.5eCFR. 21 CFR 111.75 – What Must You Do to Determine Whether Specifications Are Met? This is not a sampling program. Every shipment of every dietary ingredient gets tested. A company can petition FDA under 21 CFR 10.30 for an exemption, but only by showing that an alternative approach gives equivalent assurance of identity, and those exemptions are granted rarely.
The Quality Control Unit
Quality control is the regulatory backbone of the operation. QC personnel must approve or reject all processes, specifications, written procedures, controls, tests, and deviations that could affect the identity, purity, strength, or composition of a product.6eCFR. 21 CFR Part 111 Subpart F – Production and Process Control System That authority reaches supplier qualification documents, in-process specifications, and the basis for any testing exemptions.
When a batch fails to meet specifications, QC must conduct a material review and make a documented disposition decision before anything happens to the batch. Reprocessing, treating a component, or making an in-process adjustment all require QC review, a scientifically valid rationale, and QC approval, and any reprocessed batch still has to meet all product specifications before release.1Food and Drug Administration. Small Entity Compliance Guide: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements QC is also responsible for collecting representative samples during production and holding reserve samples of each distributed lot for later testing if a problem surfaces after the product is on shelves.
Master and Batch Manufacturing Records
Every unique formulation and batch size requires a written master manufacturing record. It functions as the definitive recipe: name of the supplement, strength or measure of each dietary ingredient per batch size, and written instructions for every stage of manufacturing.7eCFR. 21 CFR 111.205 – What Is the Master Manufacturing Record? Those instructions must call out the specific points where control is necessary to protect quality, such as temperature ranges, mixing times, or the order in which ingredients are added.8eCFR. 21 CFR 111.210 – What Must the Master Manufacturing Record Include?
Manual operations require a two-person verification system. One person weighs or measures a component; a second verifies the weight or measure. One person adds the component; a second verifies the addition. Weighing and addition errors are among the most common causes of out-of-specification batches, and the redundancy is designed to catch them at the source.
The batch production record then documents what actually happened compared to what the master record prescribed. It must capture the batch, lot, or control number of the finished product, the identity of equipment and processing lines used, and the lot numbers assigned to each lot of packaged and labeled supplement.9eCFR. 21 CFR 111.260 – What Must the Batch Record Include? Deviations from the master record must be documented and reviewed by QC.
Facility, Equipment, and Personnel
The plant itself has to be kept clean, sanitary, and in good repair so that components and finished supplements are never exposed to contamination. Cleaning compounds and sanitizing agents must be safe and free from harmful microorganisms, and toxic materials like pesticides or industrial chemicals can only be present if they serve a necessary purpose and are stored away from production surfaces.10eCFR. 21 CFR 111.15 – What Sanitation Requirements Apply to Your Physical Plant and Its Grounds?
Equipment must be built and maintained so that it can be cleaned properly and will not contaminate the products it touches. Contact surfaces have to be corrosion-resistant and made of nontoxic materials. The regulation specifically names lubricants, fuel, coolants, metal or glass fragments, and contaminated water as hazards equipment design must guard against.11eCFR. 21 CFR 111.27 – What Requirements Apply to the Equipment and Utensils That You Use?
Calibration is mandatory. Every instrument and control used in manufacturing or testing must be calibrated before first use, then at intervals specified by the manufacturer or often enough to maintain accuracy. Instruments that cannot be adjusted to a reference standard must be repaired or replaced. This is one of the first things an FDA inspector looks for, and missing calibration logs reliably trigger warning letters.
Everyone involved in manufacturing, packaging, labeling, holding, or quality control must have the education, training, or experience needed to do the job.12eCFR. 21 CFR 111.12 – What Requirements Apply to the Qualifications of Personnel Who Manufacture, Package, Label, or Hold Dietary Supplements? The regulation does not prescribe specific degrees; it puts the burden on the company to show that its people are qualified for what they do. Training records must document the date, the type of training, and who received it. Workers must wear outer garments that protect components and contact surfaces from contamination, use hair restraints where appropriate, and stay away from direct product contact when sick or infected.13eCFR. 21 CFR 111.10 – What Requirements Apply for Preventing Microbial Contamination From Sick or Infected Personnel and for Hygienic Practices?
Packaging, Labeling, and Holding
Packaging must protect the supplement from physical damage, moisture, and microbial contamination during shipping and storage. Before labeling begins, workers must confirm that labels match the specific batch and formulation being packaged.
Storage conditions matter. Components and finished supplements must be held under temperature, humidity, and light conditions that preserve their identity, purity, strength, and composition. Labels and packaging materials must be stored separately under conditions that prevent deterioration or mix-ups with materials intended for other products.14eCFR. 21 CFR 111.455 – What Requirements Apply to Holding Components, Dietary Supplements, Packaging, and Labels?
Expiration Dating
Part 111 does not require every supplement to carry an expiration date, but a date on the label has to be supported by data. Federal law explicitly contemplates “expiration date labeling, when necessary” within the CGMP framework.2Office of the Law Revision Counsel. 21 USC 342 – Adulterated Food That means stability testing, typically both real-time studies at normal storage temperatures and accelerated studies under high heat and humidity. If your label promises 500 mg of vitamin C per serving through a given date, you need documented evidence the product actually delivers that amount through that date.
Complaints and Adverse Event Reporting
A qualified person must review every product complaint to determine whether it involves a possible failure to meet any specification or other regulatory requirement. If the complaint suggests a potential risk of illness or injury, the company must investigate, and QC personnel must review and approve both the decision to investigate and the findings.15eCFR. 21 CFR 111.560 – What Requirements Apply to the Review and Investigation of a Product Complaint? Investigations must extend to all relevant batches and records, not only the one a consumer named.
Serious adverse events sit on a separate, faster track under the Dietary Supplement and Nonprescription Drug Consumer Protection Act. When a manufacturer or distributor receives a report of an adverse event resulting in death, a life-threatening condition, hospitalization, disability, or a congenital abnormality, it must report the event to FDA within 15 business days.16Office of the Law Revision Counsel. 21 USC 379aa-1 – Serious Adverse Event Reporting for Dietary Supplements Any new medical information received within the following year must also be submitted within 15 business days, and all adverse event records must be kept for six years.
Returned Supplements
Products that come back from customers or distributors create a specific compliance problem. A returned supplement can only be reprocessed if it meets all product specifications, and QC must approve or reject the release of every reprocessed return. Returns that cannot meet specifications must be destroyed.17eCFR. 21 CFR 111.525 – What Requirements Apply to a Returned Dietary Supplement? For many companies the practical default is to destroy all returns, because the documentation and QC burden of reprocessing costs more than the recovered product is worth.
Recordkeeping
Records required under Part 111 must be retained for one year past the shelf life date if the product carries one, or two years beyond the distribution date of the last batch associated with those records if no shelf life date is used.18eCFR. 21 CFR Part 111 Subpart P – Records and Recordkeeping Records have to remain legible, protected from deterioration, and readily available for FDA inspection and copying. Adverse event records are the exception to those timeframes, retained for six years under the separate statute above.
Companies that use electronic systems instead of paper must also comply with 21 CFR Part 11, which governs when electronic records and electronic signatures are treated as legally equivalent to paper. That means validated systems, secure time-stamped audit trails covering every creation, modification, or deletion, role-based access controls, and written policies that hold individuals accountable for actions taken under their electronic signatures.19eCFR. 21 CFR Part 11 – Electronic Records; Electronic Signatures An unvalidated electronic system is treated as no records at all.
What Happens If You Don’t Comply
A supplement made under conditions that don’t meet CGMP is adulterated under federal law.2Office of the Law Revision Counsel. 21 USC 342 – Adulterated Food Warning letters are the most common opening move. Recent FDA letters have cited failures like not establishing finished product specifications for identity, purity, strength, and composition, and not documenting material review and disposition decisions.20U.S. Food and Drug Administration. Eniva USA, Inc. Warning Letter 706565
Uncorrected problems can escalate to product seizures, import alerts blocking foreign shipments at the border, injunctions shutting down manufacturing, or criminal prosecution. A warning letter alone carries real weight because it becomes public record and can cost customer and retailer confidence within a single news cycle.